6.
di Pasquo E, Giannubilo S, Valentini B, Salvi S, Rullo R, Fruci S
. The "Preeclampsia and Hypertension Target Treatment" study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings. Am J Obstet Gynecol MFM. 2024; 6(5):101368.
DOI: 10.1016/j.ajogmf.2024.101368.
View
7.
Roberts J, Rich-Edwards J, McElrath T, Garmire L, Myatt L
. Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness. Hypertension. 2021; 77(5):1430-1441.
PMC: 8103569.
DOI: 10.1161/HYPERTENSIONAHA.120.14781.
View
8.
Alavifard S, Chase R, Janoudi G, Chaumont A, Lanes A, Walker M
. First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis. Pregnancy Hypertens. 2019; 18:179-187.
DOI: 10.1016/j.preghy.2019.09.019.
View
9.
Vermillion S, Scardo J, Newman R, Chauhan S
. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol. 1999; 181(4):858-61.
DOI: 10.1016/s0002-9378(99)70314-5.
View
10.
Clark S, Belfort M, Dildy G, Herbst M, Meyers J, Hankins G
. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 2008; 199(1):36.e1-5.
DOI: 10.1016/j.ajog.2008.03.007.
View
11.
Di Martino D, Stampalija T, Zullino S, Fuse F, Garbin M, Parasiliti M
. Maternal hemodynamic profile during pregnancy and in the post-partum in hypertensive disorders of pregnancy and fetal growth restriction. Am J Obstet Gynecol MFM. 2022; 5(3):100841.
DOI: 10.1016/j.ajogmf.2022.100841.
View
12.
McLaughlin K, Snelgrove J, Sienas L, Easterling T, Kingdom J, Albright C
. Phenotype-Directed Management of Hypertension in Pregnancy. J Am Heart Assoc. 2022; 11(7):e023694.
PMC: 9075436.
DOI: 10.1161/JAHA.121.023694.
View
13.
Shi D, Yang F, Zhou L, Wang N
. Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia. J Clin Pharm Ther. 2016; 41(6):657-661.
DOI: 10.1111/jcpt.12439.
View
14.
Perry H, Binder J, Gutierrez J, Thilaganathan B, Khalil A
. Maternal haemodynamic function differs in pre-eclampsia when it is associated with a small-for-gestational-age newborn: a prospective cohort study. BJOG. 2020; 128(2):167-175.
DOI: 10.1111/1471-0528.16269.
View
15.
Palmrich P, Haase N, Sugulle M, Kalafat E, Khalil A, Binder J
. Maternal haemodynamics in Hypertensive Disorders of Pregnancy under antihypertensive therapy (HyperDiP): study protocol for a prospective observational case-control study. BMJ Open. 2023; 13(6):e065444.
PMC: 10254794.
DOI: 10.1136/bmjopen-2022-065444.
View
16.
Valensise H, Vasapollo B, Gagliardi G, Novelli G
. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008; 52(5):873-80.
DOI: 10.1161/HYPERTENSIONAHA.108.117358.
View
17.
Tay J, Foo L, Masini G, Bennett P, Mceniery C, Wilkinson I
. Early and late preeclampsia are characterized by high cardiac output, but in the presence of fetal growth restriction, cardiac output is low: insights from a prospective study. Am J Obstet Gynecol. 2018; 218(5):517.e1-517.e12.
DOI: 10.1016/j.ajog.2018.02.007.
View
18.
Lorenzo C, Aung K, Stern M, Haffner S
. Pulse pressure, prehypertension, and mortality: the San Antonio heart study. Am J Hypertens. 2009; 22(11):1219-26.
DOI: 10.1038/ajh.2009.151.
View
19.
Menzies J, Magee L, Li J, MacNab Y, Yin R, Stuart H
. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Obstet Gynecol. 2007; 110(1):121-7.
DOI: 10.1097/01.AOG.0000266977.26311.f0.
View
20.
von Dadelszen P, Magee L, Roberts J
. Subclassification of preeclampsia. Hypertens Pregnancy. 2003; 22(2):143-8.
DOI: 10.1081/PRG-120021060.
View